| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | narciclasine | CTRPv2 | pan-cancer | AAC | 0.0088 | 0.8 |
| mRNA | Axitinib | CTRPv2 | pan-cancer | AAC | -0.0089 | 0.8 |
| mRNA | N9-isopropylolomoucine | CTRPv2 | pan-cancer | AAC | -0.0094 | 0.8 |
| mRNA | PF-750 | CTRPv2 | pan-cancer | AAC | 0.0097 | 0.8 |
| mRNA | UNC1215 | GDSC1000 | pan-cancer | AAC | 0.0089 | 0.8 |
| mRNA | Vinorelbine | GDSC1000 | pan-cancer | AAC | -0.0091 | 0.8 |
| mRNA | BI-2536 | GDSC1000 | pan-cancer | AAC | -0.014 | 0.8 |
| mRNA | lapatinib | FIMM | pan-cancer | AAC | 0.044 | 0.8 |
| mRNA | LE-135 | CTRPv2 | pan-cancer | AAC | 0.0088 | 0.8 |
| mRNA | VX-680 | CTRPv2 | pan-cancer | AAC | -0.03 | 0.8 |